Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart

Lian-Yu Lin1, Mao-Yuan M Su, Jien-Jiun Chen

  • 1Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Insights

Identifying the conductive channel (CC) via late gadolinium enhanced-cardiac magnetic resonance (LGE-CMR) can help identify patients with heart failure (HF) at risk for ventricular tachycardia (VT). This imaging technique shows a higher probability of CC identification in patients experiencing VT/VF or mortality.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Electrophysiology

Background:

  • Late gadolinium enhanced-cardiac magnetic resonance (LGE-CMR) can detect conductive channels (CC) formed by heterogeneous tissue within myocardial scar.
  • These CCs are implicated as the source of ventricular tachycardia (VT) in patients.

Purpose of the Study:

  • To evaluate the association between CCs identified by LGE-CMR and the occurrence of VT in patients with systolic heart failure (HF).
  • To determine if CC identification can predict VT risk in HF patients.

Main Methods:

  • Sixty-three patients with left ventricular ejection fraction (LVEF) < 50% and LGE-CMR hyperenhancement were analyzed.
  • Cardiac magnetic resonance (CMR) imaging was used to assess LV function, scar characteristics, and identify CCs.
  • Patient outcomes, including VT, ventricular fibrillation (VF), and mortality, were tracked via medical records.

Main Results:

  • CC identification by LGE-CMR was significantly higher in patients who experienced VT/VF (75.0%) compared to those who did not (16.4%, p < 0.001).
  • CC identification was also significantly higher in patients who died (50.0%) versus survivors (16.3%, p = 0.004).
  • CC identification was positively associated with VT/VF (HR: 27.032) and mortality (HR: 4.766), while LVEF was inversely associated with both outcomes.

Conclusions:

  • LGE-CMR identification of the conductive channel (CC) is a significant predictor of VT/VF events in patients with systolic heart failure.
  • This imaging approach can aid in identifying HF patients at higher risk for life-threatening ventricular arrhythmias.
Abstract

Related Concept Videos

Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
947
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.2K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
564
Conduction System of the Heart01:20

Conduction System of the Heart

The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
6.1K
Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
13.7K
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
735